References
1. Vithoulkas G, Carlino S. The “continuum” of a unified theory of
diseases. Med Sci Monit 2010; 16 :15.
2. Serhan CN, Savill J. Resolution of inflammation: the beginning
programs the end. Nat Immunol 2005; 6 :1191-7.
3. Rajakariar R, Yaqoob MM, Gilroy DW. COX-2 in inflammation and
resolution. Molecular interventions 2006; 6 :199.
4. Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of
immunity: the immune system feels the heat. Nature Reviews
Immunology 2015; 15 :335-49.
5. Sibley W, Bamford C, Clark K. Clinical viral infections and multiple
sclerosis. The Lancet 1985; 325 :1313-5.
6. Torres AR. Is fever suppression involved in the etiology of autism
and neurodevelopmental disorders? BMC Pediatrics 2003; 3 :9.
7. Megremi ASF. Is fever a predictive factor in the autism spectrum
disorders? Medical Hypotheses 2013; 80 :391-8.
8. Hobohm U. Fever therapy revisited. Br J Cancer 2005;92 :421-5.
9. Hahnemann S. Organon of medicine: B. Jain publishers, 2002.
10. Vithoulkas G. Levels of health. 3rd revised edition
Edn. Alonissos, Greece: International Academy of Classical Homeopathy,
2019.
11. GBDCoD C. Global, regional, and national age-sex-specific mortality
for 282 causes of death in 195 countries and territories, 1980-2017: a
systematic analysis for the Global Burden of Disease Study 2017.Lancet 2018; 392 :1736-88.
12. Fisher DT, Vardam TD, Muhitch JB, Evans SS. Fine-tuning immune
surveillance by fever-range thermal stress. Immunol Res 2010;46 :177-88.
13. Wallace JL. COX-2: A Pivotal Enzyme in Mucosal Protection and
Resolution of Inflammation. TheScientificWorldJOURNAL 2006;6 :941592.
14. Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J,
Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M,
Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent
and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory
Bowel Disease. Frontiers in immunology 2019; 10 :1699-.
15. Loynes CA, Lee JA, Robertson AL, Steel MJ, Ellett F, Feng Y, Levy
BD, Whyte MKB, Renshaw SA. PGE2 production at sites of tissue injury
promotes an anti-inflammatory neutrophil phenotype and determines the
outcome of inflammation resolution in vivo. Science Advances
2018; 4 :eaar8320.
16. Lawrence T, Gilroy DW. Chronic inflammation: a failure of
resolution? International journal of experimental pathology 2007;88 :85-94.
17. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of
patients with COVID-19: evidence from meta-analysis. Aging 2020;12 :6049-57.
18. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani
E, De Benedictis G. Inflamm-aging: An Evolutionary Perspective on
Immunosenescence. Annals of the New York Academy of Sciences
2000; 908 :244-54.
19. Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M.
Immunosenescence and infectious diseases. Microbes and Infection
2001; 3 :851-7.